Thanks to visit codestin.com
Credit goes to dbpedia.org
Browse using
OpenLink Faceted Browser
OpenLink Structured Data Editor
LodLive Browser
Formats
RDF:
N-Triples
N3
Turtle
JSON
XML
OData:
Atom
JSON
Microdata:
JSON
HTML
Embedded:
JSON
Turtle
Other:
CSV
JSON-LD
Faceted Browser
Sparql Endpoint
About:
Monoclonal antibody therapy
An Entity of Type:
Thing
,
from Named Graph:
http://dbpedia.org
,
within Data Space:
dbpedia.org
Form of immunotherapy
Property
Value
dbo:
description
form of immunotherapy
(en)
免疫療法的形式
(zh)
dbo:
thumbnail
wiki-commons
:Special:FilePath/Antibody.svg?width=300
dbo:
wikiPageExternalLink
https://www.accessdata.fda.gov/drugsatfda_docs/label/1996/capcyt102896lab.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/1997/abcicen110597-lab.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/1997/ritugen112697-lab.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/basnov051298lb.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/inflcen082498lb.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/trasgen092598lb.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/adalabb123102LB.htm
https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/daclhof072902lb.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/ibriide021902LB.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/palimed102302LB.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/omalgen062003LB.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/125084lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/125085lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/125104lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/125147s0000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/125156lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/103948s5070lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/125166lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/125160s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/125261lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/125289s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/125319s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/125326lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/125276lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/125320s0000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/125370s0000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/125377s0000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/125388s000,125399s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/125349s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/125409lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125427lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125433s000lbledt.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125472s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125486s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125476s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125477lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125496s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125514lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125554lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125557lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125504s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125516s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125522s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125526Orig1s000Lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125527s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125547s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125559Orig1s000lbledt.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/761025lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/761035s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/761036Orig1s000lbledt.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125509lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125521s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125544s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761024lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761029s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761033lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761034Orig1s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761038lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761041s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761044lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761046s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761028s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761032lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761037s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761040s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761049s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761053lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761054Orig1s000lbledt.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761055lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761058lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761060lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761061s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761064s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761069s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761070s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761072s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761074s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761083s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761065lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761067s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761068s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761077s000lbl.pdf
http://www.cancernetwork.com/cancer-management-11/chapter03/article/10165/1402628
dbo:
wikiPageInterLanguageLink
dbpedia-sl
:Biološka_zdravila
dbo:
wikiPageWikiLink
dbr
:Ibritumomab_tiuxetan
dbr
:CD19
dbr
:Biogen
dbr
:Juvenile_idiopathic_arthritis
dbr
:Familial_hypercholesterolemia
dbr
:Human_Genome_Sciences
dbr
:In_vivo
dbr
:Hypercholesterolemia
dbr
:Cryopyrin-associated_periodic_syndrome
dbc
:Immunology
dbr
:Merck_&_Co.
dbr
:Half-life
dbr
:AstraZeneca
dbr
:Allotype_(immunology)
dbr
:Hypervariable_region
dbr
:Respiratory_syncytial_virus
dbr
:Alzheimer's_disease
dbr
:Asthma
dbr
:Transplant_rejection
dbr
:Follicular_lymphoma
dbr
:Osteoporosis
dbr
:Eli_Lilly
dbc
:Monoclonal_antibodies_for_tumors
dbr
:Natalizumab
dbr
:Obinutuzumab
dbr
:Bacillus_anthracis
dbr
:Boehringer_Ingelheim
dbr
:Chronic_lymphocytic_leukemia
dbr
:Renal_cell_carcinoma
dbr
:Radioimmunotherapy
dbr
:Mepolizumab
dbr
:GD2
dbr
:Antigen
dbr
:Bevacizumab
dbr
:Blinatumomab
dbr
:CD4
dbc
:Antiviral_drugs
dbr
:Catumaxomab
dbr
:Certolizumab_pegol
dbr
:Daclizumab
dbr
:Denosumab
dbr
:Factor_VIII
dbr
:Gemtuzumab_ozogamicin
dbr
:Integrin
dbr
:Interleukin_6
dbr
:Metabolite
dbr
:Ofatumumab
dbr
:Palivizumab
dbr
:Papain
dbr
:Rituximab
dbr
:Transferrin
dbr
:Trastuzumab
dbr
:Anaplastic_large-cell_lymphoma
dbr
:Genentech
dbr
:Hyaluronidase
dbr
:Janssen_Biotech
dbr
:Mylan
dbr
:Takeda_Pharmaceutical_Company
dbr
:UCB_(company)
dbr
:Wyeth
dbr
:Phage_display
dbr
:Immunotherapy
dbr
:Tositumomab
dbr
:Crohn's_disease
dbr
:HIV
dbr
:Immune_system
dbr
:Ulcerative_colitis
dbr
:Abciximab
dbr
:Extracellular_matrix
dbr
:Corticosteroid
dbr
:Hodgkin_lymphoma
dbr
:MedImmune
dbr
:Paroxysmal_nocturnal_hemoglobinuria
dbr
:Prostatectomy
dbr
:Interleukin_12
dbr
:Ipilimumab
dbr
:Tumor_antigen
dbr
:Bezlotoxumab
dbr
:Benralizumab
dbr
:CD30
dbr
:Glutamate_carboxypeptidase_II
dbr
:Brodalumab
dbr
:Cell_(biology)
dbr
:Multiple_sclerosis
dbr
:Protein
dbr
:Immune_complex
dbr
:Polymerase_chain_reaction
dbr
:Novartis
dbr
:Daratumumab
dbr
:Antibody
dbr
:Immunoglobulin_E
dbr
:Immunoglobulin_G
dbr
:Breast_cancer
dbr
:Alemtuzumab
dbr
:Amyloid_beta
dbr
:Apolipoprotein
dbr
:Basiliximab
dbr
:Brentuximab_vedotin
dbr
:Cetuximab
dbr
:Complement_component_5
dbr
:Dabigatran
dbr
:Eculizumab
dbr
:Epidermal_growth_factor_receptor
dbr
:Factor_X
dbr
:Fusion_protein
dbr
:Golimumab
dbr
:HER2
dbr
:Infliximab
dbr
:Monoclonal_antibody
dbr
:Ocrelizumab
dbr
:Omalizumab
dbr
:Panitumumab
dbr
:RANKL
dbr
:Ranibizumab
dbr
:Tocilizumab
dbr
:Ustekinumab
dbr
:Colorectal_cancer
dbr
:Rheumatoid_arthritis
dbr
:Pfizer
dbr
:Canakinumab
dbr
:Elotuzumab
dbr
:Siltuximab
dbr
:Anaphylactic_shock
dbr
:Autoimmune_and_inflammatory_disorder
dbr
:Erenumab-aooe
dbr
:Acute_myeloid_leukemia
dbr
:Atopic_dermatitis
dbr
:Cancer
dbr
:Diffuse_large_B-cell_lymphoma
dbr
:Prostate_cancer
dbr
:Psoriatic_arthritis
dbr
:Cervical_cancer
dbr
:Merck_Group
dbr
:Indoleamine_2,3-dioxygenase
dbr
:Belimumab
dbr
:Percutaneous_coronary_intervention
dbr
:Pertuzumab
dbr
:Anthrax_toxin
dbr
:Spectrum_Pharmaceuticals
dbr
:Adalimumab
dbr
:Biosimilar
dbr
:Amgen
dbr
:Proteomics
dbr
:In_vitro
dbr
:Immunogenicity
dbr
:CD20
dbr
:CD22
dbr
:Sarilumab
dbr
:Glioblastoma
dbr
:Multiple_myeloma
dbr
:Genzyme
dbr
:Inotuzumab_ozogamicin
dbr
:Active_immunization
dbr
:Necitumumab
dbr
:Ixekizumab
dbr
:Idarucizumab
dbr
:VEGFR1
dbr
:Passive_immunity
dbr
:Ramucirumab
dbr
:Raxibacumab
dbr
:Nivolumab
dbr
:Secukinumab
dbr
:Evolocumab
dbr
:VEGFR2
dbr
:TNF_alpha
dbr
:Fc_region
dbr
:VEGF
dbr
:Cerebrospinal_fluid
dbr
:Escherichia_coli
dbr
:Nucleotide
dbc
:Monoclonal_antibodies
dbr
:Ankylosing_spondylitis
dbr
:Neuroblastoma
dbr
:Adaptive_immune_system
dbr
:Tumor_microenvironment
dbr
:X-linked_hypophosphatemia
dbr
:Alirocumab
dbr
:Autoimmune_disease
dbr
:Alexion
dbr
:Stromal_cell
dbr
:Interleukin_23
dbr
:Systemic_lupus_erythematosus
dbr
:CTLA-4
dbr
:Castleman's_disease
dbr
:Humanized_antibody
dbr
:ImClone_Systems
dbr
:Regeneron_Pharmaceuticals
dbr
:Olaratumab
dbr
:Centocor
dbr
:Clinical_trials
dbr
:Mogamulizumab
dbr
:Monospecific_antibody
dbr
:Active_immunity
dbr
:Acute_organ_rejection
dbr
:Adalimumab-adbm
dbr
:Adalimumab-atto
dbr
:Dupilumab
dbr
:Reslizumab
dbr
:Teva_Pharmaceutical_Industries
dbr
:Vaccines
dbr
:Malignant
dbr
:Merkel_cell_carcinoma
dbr
:Vedolizumab
dbr
:Moxetumomab_pasudotox
dbr
:Checkpoint_inhibitor
dbr
:Organ_transplant
dbr
:Autoimmune_diseases
dbr
:Neoplasms
dbr
:T_cells
dbr
:Bristol-Myers_Squibb
dbr
:T-cell
dbr
:Monoclonal_antibodies
dbr
:Extracellular
dbr
:Polypeptide
dbr
:Antibody-drug_conjugate
dbr
:ADEPT_(medicine)
dbr
:Pembrolizumab
dbr
:Cemiplimab
dbr
:Antibodies
dbr
:Mutations
dbr
:PDGFRA
dbr
:IL17RA
dbr
:SLAMF7
dbr
:Avelumab
dbr
:CCR4
dbr
:CD33
dbr
:CD52
dbr
:CD79B
dbr
:IL2RA
dbr
:PD-L1
dbr
:United_Therapeutics
dbr
:Antibody-dependent_cellular_cytotoxicity
dbr
:PD-1
dbr
:Abbvie
dbr
:Clostridium_difficile_toxin_B
dbr
:Elusys_Therapeutics
dbr
:CD38
dbr
:Interleukin_5
dbr
:Guselkumab
dbr
:Durvalumab
dbr
:Polatuzumab_vedotin
dbr
:Atezolizumab
dbr
:Obiltoxaximab
dbr
:Dinutuximab
dbr
:PCSK9
dbr
:Ultragenyx
dbr
:Hoffmann-La_Roche
dbr
:Radioactive
dbr
:Allergic_reaction
dbr
:Ebola_virus_disease
dbr
:Blood_serum
dbr
:Murine
dbr
:Blood-brain_barrier
dbr
:Organ_rejection
dbr
:IgE
dbr
:Gastric_cancer
dbr
:IL17A
dbr
:Endothelin_B_receptor
dbr
:Liposomes
dbr
:Myelomonocytic
dbr
:Tildrakizumab-asmn
dbr
:Non-small-cell_lung_carcinoma
dbr
:IL1B
dbr
:Celltrion_Healthcare
dbr
:EMD_Serono
dbr
:Plaque_psoriasis
dbr
:TNF
dbr
:Transgenic
dbr
:GlaxoSmithKline
dbr
:Immunoglobulin
dbr
:Seattle_Genetics
dbr
:Hemophilia_A
dbr
:Heterodimer
dbr
:OKT3
dbr
:Cytogen
dbr
:Factor_IXa
dbr
:File:Monoclonal_antibodies.svg
dbr
:Glaxo_Grp
dbr
:Infliximab-qbtx
dbr
:Interleukin-5_receptor_alpha_subunit
dbr
:Peripheral_Sink_hypothesis
dbr
:Phospho-tau_expression
dbr
:Samsung_Bioepis
dbr
:Ado-trastuzumab_emtansine
dbr
:Amyloid_hypothesis
dbr
:Analog_(chemistry)
dbr
:Burosumab-twza
dbr
:Fibroblasts
dbr
:B-cell_chronic_lymphocytic_leukemia
dbr
:Clostridium_difficile_infection
dbr
:File:Antibody.svg
dbr
:BLyS
dbr
:Bevacizumab-awwb
dbr
:Metastatic_melanoma
dbr
:Precursor_B-cell_acute_lymphoblastic_leukemia
dbr
:Wet_age-related_macular_degeneration
dbr
:Biogen_Idec
dbr
:Bispecific_antibodies
dbr
:Lymphomas
dbr
:Cytotoxic
dbp:
bot
medic
(en)
dbp:
date
2009-05-15
(xsd:date)
May 2025
(en)
dbp:
url
https://web.archive.org/web/20090515221337/http:/www.cancernetwork.com/cancer-management-11/chapter03/article/10165/1402628
dbp:
wikiPageUsesTemplate
dbt
:Mainlist
dbt
:Reflist
dbt
:Dead_link
dbt
:See_also
dbt
:Update_section
dbt
:Further
dbt
:Cbignore
dbt
:As_of
dbt
:Registration_required
dbt
:Cn
dbt
:Webarchive
dbt
:Extracellular_chemotherapeutic_agents
dbt
:Short_description
dct:
subject
dbc
:Immunology
dbc
:Monoclonal_antibodies_for_tumors
dbc
:Antiviral_drugs
dbc
:Monoclonal_antibodies
gold:
hypernym
dbr
:Form
rdfs:
label
Monoclonal antibody therapy
(en)
العلاج بالأضداد وحيدة النسيلة
(ar)
Терапія з використанням моноклональних антитіл
(uk)
單株抗體治療
(zh)
rdfs:
seeAlso
dbr
:Monoclonal_antibody
owl:
sameAs
freebase
:Monoclonal antibody therapy
yago-res
:Monoclonal antibody therapy
wikidata
:Monoclonal antibody therapy
dbpedia-zh
:Monoclonal antibody therapy
dbpedia-fa
:Monoclonal antibody therapy
dbpedia-ar
:Monoclonal antibody therapy
dbpedia-hy
:Monoclonal antibody therapy
dbpedia-uk
:Monoclonal antibody therapy
dbpedia-global
:Monoclonal antibody therapy
skos:
broadMatch
http://www.springernature.com/scigraph/things/subjects/antibody-fragment-therapy
prov:
wasDerivedFrom
wikipedia-en
:Monoclonal_antibody_therapy?oldid=1293095757&ns=0
foaf:
depiction
wiki-commons
:Special:FilePath/Antibody.svg
wiki-commons
:Special:FilePath/Monoclonal_antibodies.svg
foaf:
isPrimaryTopicOf
wikipedia-en
:Monoclonal_antibody_therapy
is
dbo:
wikiPageDisambiguates
of
dbr
:Antibody_therapy
is
dbo:
wikiPageRedirects
of
dbr
:Monoclonal_antibody_therapeutic
dbr
:Monoclonal_antibody_therapy_of_cancer
dbr
:Therapeutic_antibodies
dbr
:Therapeutic_antibody
dbr
:Therapeutic_monoclonal_antibodies
dbr
:Antibody_therapeutics
is
dbo:
wikiPageWikiLink
of
dbr
:Ibritumomab_tiuxetan
dbr
:Medical_procedure
dbr
:Human_anti-mouse_antibody
dbr
:Oral_cancer
dbr
:Allen_West_(politician)
dbr
:Nodular_lymphocyte_predominant_Hodgkin_lymphoma
dbr
:Index_of_immunology_articles
dbr
:Oligoclonal_antibody
dbr
:Senile_osteoporosis
dbr
:Baxter_International
dbr
:L1_(protein)
dbr
:Calcitonin_gene-related_peptide_receptor_antagonist
dbr
:CCL17
dbr
:Small_modular_immunopharmaceutical
dbr
:Eli_Lilly_and_Company
dbr
:Donald_L._Drakeman
dbr
:Tityustoxin
dbr
:Eosinophil
dbr
:Bill_&_Melinda_Gates_Foundation
dbr
:Eisai_(company)
dbr
:Yttrium
dbr
:Index_of_oncology_articles
dbr
:Therapy
dbr
:Acquired_C1_esterase_inhibitor_deficiency
dbr
:MDX-1097
dbr
:Ansuvimab
dbr
:Antibody
dbr
:Diffuse_large_B-cell_lymphoma
dbr
:Cholesterol
dbr
:Polyclonal_B_cell_response
dbr
:Directed_evolution
dbr
:Immunoconjugate
dbr
:Small_molecule
dbr
:Undifferentiated_pleomorphic_sarcoma
dbr
:Nomenclature_of_monoclonal_antibodies
dbr
:University_of_California,_Berkeley
dbr
:Vaccine_Research_Center
dbr
:CiteAb
dbr
:List_of_therapies
dbr
:Xavier_Pivot
dbr
:Neuroblastoma
dbr
:List_of_therapeutic_monoclonal_antibodies
dbr
:3F8
dbr
:La_Trobe_Institute_for_Molecular_Science
dbr
:G._Dhinakar_Raj
dbr
:Treatment_of_cancer
dbr
:Ology_Bioservices
dbr
:Inflammatory_cytokine
dbr
:Synthetic_immunology
dbr
:Indolent_lymphoma
dbr
:Operation_Warp_Speed
dbr
:Bijvoet_Centre_for_Biomolecular_Research
dbr
:ZMapp
dbr
:CKLF_like_MARVEL_transmembrane_domain_containing_6
dbr
:VISTA_(protein)
dbr
:Complement-dependent_cytotoxicity
dbr
:Antibody_therapy
dbr
:Ionis_Pharmaceuticals
dbr
:Margetuximab
dbr
:AbCellera
dbr
:Treatment_and_management_of_COVID-19
dbr
:Otilimab
dbr
:Endothelial_cell_tropism
dbr
:Monoclonal_antibody_therapeutic
dbr
:Monoclonal_antibody_therapy_of_cancer
dbr
:Therapeutic_antibodies
dbr
:Therapeutic_antibody
dbr
:Therapeutic_monoclonal_antibodies
dbr
:Cancer_signs_and_symptoms
dbr
:Antibody_therapeutics
is
rdfs:
seeAlso
of
dbr
:Monoclonal_antibody
dbr
:Biological_response_modifier
is
foaf:
primaryTopic
of
wikipedia-en
:Monoclonal_antibody_therapy
This content was extracted from
Wikipedia
and is licensed under the
Creative Commons Attribution-ShareAlike 4.0 International